Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer

The dependency of prostate cancer (PCa) growth on androgen receptor (AR) signaling has been harnessed to develop first-line therapies for high-risk localized and metastatic PCa treatment. However, the occurrence of aberrant expression, mutated or splice variants of AR confers resistance to androgen...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Lett
Main Authors: Wang, Shan, Gilbreath, Collin, Kollipara, Rahul K., Sonavane, Rajni, Huo, Xiaofang, Yenerall, Paul, Das, Amit, Ma, Shihong, Raj, Ganesh V., Kittler, Ralf
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7370677/
https://ncbi.nlm.nih.gov/pubmed/32485222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2020.05.027
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items